Techsomed Medical Technologies
About Techsomed Medical Technologies
TechsoMed Medical Technologies is a medical imaging software company dedicated to significantly enhancing clinical outcomes in Oncology, Cardiology, and Pain Management. Their flagship product, BioTraceIO 360, is an AI-powered, real-time thermal ablation management system. This innovative platform seamlessly integrates with standard commercial ultrasound imaging systems, and can also leverage CT and MRI data, to provide physicians with real-time visualization and comprehensive analysis of tissue viability during thermal ablation procedures. The core objective of their technology is to optimize procedural accuracy and efficacy through patient-specific visualization, continuous monitoring, and predictive outcomes, effectively transforming traditional guesswork into data-driven guidance for interventionalists.
For physicians, BioTraceIO 360 offers critical intra-procedural feedback during minimally invasive thermal ablation treatments, which are widely applied for tumor destruction (notably in the liver and kidney), management of heart arrhythmias, and chronic pain management through radiofrequency neurotomy. The system employs advanced AI algorithms to analyze echogenicity variations and microvascular changes, generating an immediate ablation damage map that accurately estimates the extent of thermal damage 24 hours post-treatment, correlating strongly with post-procedural CECT scans. This capability enables immediate procedural adjustments, leading to improved treatment precision, minimized damage to healthy tissue, maximized target tissue ablation, and ultimately, enhanced patient outcomes with reduced recurrence rates. TechsoMed has secured FDA 510(k) clearance for its VisAble.IO software for planning liver ablation procedures and confirming ablation zones, and De Novo clearance for BioTraceIO for tissue response prediction in liver tumor ablation.
Focus Areas
Business Intelligence
| Key Investors | Johnson & Johnson Innovation – JJDC Inc., Axil Capital, SCREEN Holdings, AMIT-Alfred Mann Institute at Technion, NextLeap Ventures, 4BIO Capital, Astellas Venture Management, Remiges Ventures, Cobro Ventures, Magna Capital Partners, Radianx Capital, Yongjin Capital |
| Partnerships | Medtronic, GE HealthCare, Fraunhofer MEVIS, Juntendo University |
| Acquisitions | Joint Venture with TechsoMed Japan K.K. |
| Technology | BioTrace™ platform (BioTraceIO, BioTraceIO360, VisAble.IO), AI-powered, hardware-agnostic, integrates with standard commercial ultrasound devices, unifies CT, MRI, and ultrasound data, generative AI |
| FDA Clearances | 2+ cleared products (estimated) |
What Physicians Need to Know
For physicians, Techsomed's BioTraceu2122 platform offers unprecedented real-time feedback and predictive modeling, transforming ablation procedures from guesswork into precise, data-driven guidance. Leverage its hardware-agnostic nature to integrate seamlessly with your existing ultrasound, CT, and MRI systems. Utilize the comprehensive planning, intra-procedural guidance, and post-procedure assessment tools to optimize ablation margins, minimize damage to healthy tissue, and confirm treatment success, thereby aiming for higher efficacy and lower recurrence rates across oncology (liver, kidney), cardiology, and pain management applications. The system's ability to provide patient-specific treatment planning and predictive insights can significantly enhance clinical decision-making and improve patient outcomes.
Techsomed's BioTraceu2122 platform is designed for broad compatibility, being hardware-agnostic and integrating with standard commercial ultrasound, CT, and MRI imaging systems. This allows for seamless incorporation into existing clinical workflows without requiring specialized imaging hardware. Furthermore, Techsomed has established collaborations, such as with Medtronic, to combine their BioTraceIO360u2122 software with specific ablation devices like the Medtronic Emprintu2122 microwave ablation system, indicating potential for direct, optimized integrations with various ablation technologies. The platform unifies planning, execution, and monitoring, suggesting robust integration points across the entire image-guided therapy continuum.
Reviews & Opinions
Videos
News, demos, and interviews about Techsomed Medical Technologies.
Videos load interactively. If none appear, search YouTube for Techsomed Medical Technologies →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]